PopolareResearch VialPeptide di Ricerca Duale Incretinico
or 3 × 46,33 € interest-free
FIDATO DAI RICERCATORI
Dual Incretin Mechanism
First-in-class dual GIP/GLP-1 agonist — superior efficacy versus single-incretin agents
>99% HPLC Purity
Every batch independently tested with full Certificate of Analysis included
Extensive Clinical Evidence
SURPASS and SURMOUNT trial programs — unprecedented weight loss and glycemic results
Once-Weekly Dosing
~5-day half-life enables convenient weekly administration in research protocols
Tirzepatide è un agonista duale dei recettori GIP/GLP-1 che rappresenta l'avanguardia della scienza peptidica metabolica. Il sistema penna Peptides Pharma Tirzepatide offre un dosaggio di precisione per applicazioni di ricerca metabolica.
SELEZIONA DOSAGGIO
First-in-class dual GIP/GLP-1 agonist — superior efficacy versus single-incretin agents
Every batch independently tested with full Certificate of Analysis included
SURPASS and SURMOUNT trial programs — unprecedented weight loss and glycemic results
~5-day half-life enables convenient weekly administration in research protocols
Choose your preferred bacteriostatic water volume for dual incretin research. The lyophilized format allows custom concentration preparation.
Calculate exact doses for your metabolic research protocol. Dose titration studies (2.5mg to 15mg) require precise concentration control.
Lyophilized form stable for 24+ months when stored properly at 2-8°C. Reconstituted solution stable for 30 days refrigerated.
Research-grade tirzepatide at accessible pricing for laboratory incretin pathway studies.
Allow vial to reach room temperature before reconstitution
Add bacteriostatic water slowly along the vial wall
Gently swirl until fully dissolved — do not shake
Draw desired dose using an insulin syringe
Inject subcutaneously in the abdomen, thigh, or upper arm
Store reconstituted vial refrigerated at 2-8°C
Utilizzare sempre un ago sterile nuovo per ogni somministrazione. Smaltire gli aghi usati in un apposito contenitore per taglienti. Conservare la penna in frigorifero a 2-8°C.
Stack discount applied
Tirzepatide
139,00 €
This product
Semaglutide
129,00 €
NAD+
89,00 €
Prezzo bundle — risparmia 35,70 € con questa combinazione
Dual GIP/GLP-1 Receptor Agonist (acylated C20 fatty acid)
C225H348N48O68
4,813.45 g/mol
Approximately 5 days (116 hours)
Tirzepatide is a dual incretin agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism produces superior glycemic control and weight reduction compared to single-incretin agents by simultaneously modulating appetite, insulin secretion, and energy metabolism.
Demonstrated 22.5% mean body weight reduction with highest dose (15mg) versus 3.1% with placebo over 72 weeks — unprecedented for a pharmacological agent.
Head-to-head trial showed superior HbA1c reduction versus semaglutide 1mg, with greater weight loss across all tirzepatide doses.
Demonstrated cardiovascular safety and superior glycemic control versus insulin glargine over 52 weeks in patients with high cardiovascular risk.
“Tirzepatide represents the most significant advance in incretin biology. Peptides Pharma provides the research-grade quality needed for our dual pathway studies.”
Dr. M. Nauck
Diabetology Research, Bochum
“Our weight management research program relies on consistent tirzepatide quality. Peptides Pharma delivers every time with full documentation.”
Dr. A. Jastreboff
Obesity Research, New Haven
“The lyophilized format reconstitutes perfectly. Our internal HPLC confirmed >99.1% purity. Essential for our dose-response studies.”
Dr. S. Del Prato
Metabolic Research, Pisa
“The tirzepatide vial quality is outstanding. The lyophilized powder is well-formed and reconstitutes without issue. Our mass spectrometry analysis confirmed the dual GIP/GLP-1 structure. Delivery to France was fast and temperature-controlled.”
Dr. C. Moreau
Lyon, France
“The HPLC purity came back at 99.1% on our independent testing. Lyophilized cake was perfect — no signs of partial melt or degradation. Price is on the higher side compared to other peptides in the range, but the quality and documentation justify it.”
Oliver W.
Nottingham, UK
“We sourced tirzepatide vials from three suppliers — Peptides Pharma was clearly superior in purity and consistency. The lyophilized formulation is stable and well-characterised. Essential for our dual-incretin research programme.”
Dr. M. Bauer
Munich, Germany
Tirzepatide is a dual GIP/GLP-1 agonist while semaglutide is a pure GLP-1 agonist. In head-to-head trials (SURPASS-2), tirzepatide achieved greater weight loss and HbA1c reduction. The additional GIP receptor activation appears to provide complementary metabolic benefits.
COA incluso con ogni ordine. Report specifici per lotto disponibili su richiesta.
See how Peptides Pharma pre-mixed research vials compare to traditional vials and other suppliers.
| Feature | Peptides Pharma Pens | Traditional Vials | Other Suppliers |
|---|---|---|---|
| Format | Lyophilized vial | Lyophilised powder | Mixed |
| Purity | >99% verified | Variable (70-95%) | Claims vary |
| Dosing accuracy | <2% error | ~15% error | N/A |
| Reconstitution needed | No | Yes | Sometimes |
| Contamination risk | Sealed system | Multi-use vial | Varies |
| COA included | Every order | Rarely | Sometimes |
| GMP certified | Yes | Rarely | Some |
| EU customs-free | Yes | Often no | Varies |
Questo prodotto è destinato esclusivamente a scopi di laboratorio e ricerca. Non per consumo umano.
Sistema penna premium con dosaggio completamente regolabile. Prodotto GMP, purezza >99% garantita.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ vials with worldwide delivery from £99. >99% purity, GMP certified, COA included.
ARTICLETirzepatide hit 20.9% weight loss vs semaglutide's 14.9% in trials. We compare mechanisms, side effects, and cost. Head-to-head data inside.
ARTICLETirzepatide, semaglutide, and 3 more metabolic peptides compared. Clinical trial data, dosing, side effects, and UK pricing from €169. Expert ranked.
COMPARISONCompare semaglutide and tirzepatide for metabolic research. Single vs dual receptor, efficacy data, side effects, and dosing. Buy research-grade peptide vials.
ENCYCLOPEDIADual GIP/GLP-1 Receptor Agonist (Incretin Mimetic). Molecular weight: 4813.45 Da. Explore mechanism of action, key studies, and research applications.
BUNDLEDual-incretin approach for comprehensive metabolic research
PROTOCOLResearch protocol for Semaglutide and Tirzepatide lyophilized vials investigating GLP-1 and dual GIP/GLP-1 receptor agonism. Explore metabolic mechanisms, dose titration, and landmark clinical trial data.
FAQTirzepatide research FAQ. Learn about dual GIP/GLP-1 agonist mechanisms, metabolic research, purity, dosing, and Peptides Pharma's peptide vial system.
CATEGORYResearch-grade weight loss research vials. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Lyophilized vials, >99% purity, worldwide delivery.
CATEGORYResearch-grade peptides for body composition. Tirzepatide, CJC-1295, Ipamorelin for fat loss and lean mass. >99% purity, UK delivery.
Single and Dual Incretin Metabolic Optimization
Tirzepatide research FAQ. Learn about dual GIP/GLP-1 agonist mechanisms, metabolic research, purity, dosing, and Peptides Pharma's peptide vial system.
